We are excited to announce our vendor show with Life Science Exhibits (LSE) at Cleveland Clinic on March 4th. Come connect with the Biocytogen team and learn about our newest mouse models, latest research studies, and drug development findings that are driving advancements in biomedical research.
What is LSE Cleveland Clinic?
The Life Science Exhibits (LSE) is a premier event planning company hosting Research Supplier Product Shows across the U.S. With over 20 years of experience and more than 100 annual events, LSE connects vendors with researchers at top institutions, offering access to the latest products, reagents, and equipment.
Event Overview
Date: March 4th, 2026
Venue: EC-10 Cleveland Clinic, 9501 Euclid Ave, Cleveland, OH 44195
Event Schedule
For more information about the LSE vendor show, please visit their website here.
About BIOCYTOGEN
Biocytogen (SSE: 688796; HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR mimic antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >1,000,000 fully human antibody sequences against over 1000 targets for worldwide collaboration. As of June 30, 2025, approximately 280 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and over 50 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco, San Diego), and Germany (Heidelberg). For more information, please visit https://biocytogen.com.
We look forward to meeting you in Cleveland, Ohio!
